Rapid Mapping of Protein Interactions Using Tag‐Transfer Photocrosslinkers by Horne, J et al.
German Edition: DOI: 10.1002/ange.201809149Chemical Crosslinking
International Edition: DOI: 10.1002/anie.201809149
Rapid Mapping of Protein Interactions Using Tag-Transfer
Photocrosslinkers
Jim E. Horne+, Martin Walko+, Antonio N. Calabrese+, Mark A. Levenstein, David J. Brockwell,
Nikil Kapur, Andrew J. Wilson,* and Sheena E. Radford*
Abstract: Analysing protein complexes by chemical cross-
linking-mass spectrometry (XL-MS) is limited by the side-
chain reactivities and sizes of available crosslinkers, their slow
reaction rates, and difficulties in crosslink enrichment, espe-
cially for rare, transient or dynamic complexes. Here we
describe two new XL reagents that incorporate a methanethio-
sulfonate (MTS) group to label a reactive cysteine introduced
into the bait protein, and a residue-unbiased diazirine-based
photoactivatable XL group to trap its interacting partner(s).
Reductive removal of the bait transfers a thiol-containing
fragment of the crosslinking reagent onto the target that can be
alkylated and located by MS sequencing and exploited for
enrichment, enabling the detection of low abundance cross-
links. Using these reagents and a bespoke UV LED irradiation
platform, we show that maximum crosslinking yield is
achieved within 10 seconds. The utility of this “tag and
transfer” approach is demonstrated using a well-defined
peptide/protein regulatory interaction (BID80-102/MCL-1), and
the dynamic interaction interface of a chaperone/substrate
complex (Skp/OmpA).
Chemical crosslinking-mass spectrometry (XL-MS) is a pow-
erful component of the structural biology toolkit.[1] XL-MS
methods have been enhanced by new data analysis software,[2]
cleavable crosslinkers,[3] strategies for crosslink enrichment,[4]
footprinting reagents,[5] and structural modelling
approaches.[6] However, several challenges remain. For exam-
ple, many XL-MS reagents have limited chemical reactivities
(e.g. succinimide ester-based reagents)[7] restricting the resi-
dues for which information can be obtained. Secondly, the
low-abundance of crosslinked products often necessitates
enrichment prior to MS.[8] Finally, crosslinked peptide iden-
tification is difficult due to spectral complexity, poor frag-
mentation efficiency, and the increased search space associ-
ated with the large numbers of peptide combinations.[2] Bulky
crosslinking reagents may also perturb native interactions or
create new aberrant interactions.[9] Furthermore, many bio-
logical processes, for example, protein folding, binding and
conformational changes, occur on short timescales. Conse-
quently, crosslinks detected for a dynamic/non-equilibrium
system report the average of multiple states or are dominated
by the longest-lived state of all those populated. Photo-
crosslinkers such as diazirines can address this challenge and
have been used previously to tag Cys residues in peptides.[10]
Diazirine-generated carbenes react with proteins in ns,[11] yet
long irradiation times (minutes to hours[10b,12]) are often
required to generate acceptable crosslink yields due to the use
of low intensity lamps.
Here we exploit a “tag and transfer” approach[13] to
develop two new XL-MS reagents and a workflow that
enables crosslink identification for both well-defined and
dynamic protein-protein interactions (PPIs). These hetero-
bifunctional reagents comprise a methanethiosulfonate
(MTS) group for specific attachment onto a single Cys
residue introduced into the “bait” protein, creating a cleav-
able disulfide bond within the linker arm, and a diazirine that
crosslinks to a “target” protein (Figure 1a,b, Figure S1,S2).
Commercially available MTS-benzophenone-biotin tags have
been used in photoinduced-crosslinking (PI-XL), but these
bulky tags (752 Da) may perturb PPI interfaces.[14] In the
reagents described here, reduction of the disulfide bond-
containing linker arm between the crosslinked proteins leaves
a thiol tag on the target (87 or 204 Da in size) (Figure 1b,
Figure S3). The modified residue can then be alkylated (e.g.
with iodoacetamide [IAA]) and localised using MS protocols
for identifying post-translational modifications (PTMs),[2] or
enriched before MS. We also describe the construction of
a 365 nm UV LED irradiation platform (Figure 1c, Fig-
ure S4a,b) which enables crosslinking reactions to be com-
pleted in just 10 seconds with marginal heating. We exemplify
this methodology by mapping two PPIs, each with a different
binding mode: a complex between BID80–102 and MCL-
1 (KD = 50: 20 nm),[15] where the tight binding affinity is
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mediated by several key residues[15a,16] and the dynamic
chaperone/substrate complex Skp/OmpA (KD = 22:
16 nm),[17] in which the binding interface involves many
rapidly interconverting interactions.[17,18]
MTS-diazirine and MTS-trifluoromethyl phenyl diazirine
(MTS-TFMD) (Figure 1 a, Figure S1) were chosen as photo-
activatable groups due to the superior performance of
diazirines in comparative PI-XL studies,[12c,19] their small
size, and rapid, indiscriminate reactivity (Figure S2).[9,11] Both
diazirine- and TFMD-containing crosslinkers were synthes-
ised as the photochemistry of TFMD leads to higher cross-
linking efficiency, but it is bulkier.[20] In the bait, a unique
solvent exposed Cys for crosslinker conjugation is introduced
by mutagenesis or synthesis. In proteins/peptides which lack
Cys, or contain buried Cys, this is straightforward. When
a solvent exposed Cys is already present in the bait this can be
exploited, or substituted with Ala or Ser, and a new Cys
introduced in a location of interest. Knowing the location of
the Cys on one partner in the PPI reduces the MS/MS search
space from ntot
2 to ntarget (where ntot is the number of
crosslinkable residues in the bait and target—for diazirines,
this is every residue in the proteins—and ntarget is the number
of residues in the target). Here, we introduce a unique Cys by
mutagenesis into the E. coli outer membrane protein OmpA,
while for the BID80–102 peptide, which comprises the binding
domain of the pro-apoptotic protein BID, Cys was introduced
via solid-phase peptide synthesis. Importantly, the reactivity
of the photoactivated diazirine places no restrictions on the
amino acids in the target protein that can be detected once
a complex is formed.
To enhance diazirine photoactivation efficiency we con-
structed a 365 nm LED lamp (Figure 1c, Figure S4a,b) with
a nominal flux density of 15 Wcm@2. We designed devices to
irradiate samples in 0.2 mL to 1.5 mL tubes, or in acrylic
chips[21] with 33 mL sample wells (Figure 1c, Figure S5). Using
this LED platform, maximal XL yields were achieved in
10 seconds, with an associated heating of < 2 8C (Figure 2a,b,
Figure S4c). By contrast, a 6 W Hg-Xe lamp achieved
maximal yields after ca. 20 minutes with heating of 10 8C
(Figure 2a,b, Figure S4c), consistent with previous reports.[10-
b, 12a,b] The UV LED design thus improves the reaction rate
130-fold, and decreases heating 6-fold.
The human apoptotic regulatory pair BID/MCL-1 is
a target for cancer drug discovery.[22] The BH3 binding
domain of BID (BID80–102) adopts a helix on binding to
a surface groove on MCL-1 (Figure 3a).[15b, 16] Five single Cys
variants of BID80–102 (Figure 3a) were synthesised (see
Supporting Information), each with a unique Cys residue in
a different position. Subsequently, the peptides were tagged
with MTS-diazirine or MTS-TFMD. The modified peptides
bound MCL-1 with high affinity, although those with the
tagged residues in the centre of BID80–102 (I86C and V93C)
had a reduced EC50 (Figure 3b, Table S1). Crosslinking of the
BID80–102 peptides with MCL-1 was achieved by UV LED
irradiation. Crosslinked complexes were detected by SDS-
PAGE (Figure 3c). The absolute crosslinking efficiencies
varied from 9–40% for MTS-diazirine, with reduced effi-
ciency for lower affinity variants (Table S1). Absolute cross-
linking efficiencies were higher for the MTS-TFMD tagged
peptides (26–53%) (Table S1), as expected given the greater
yield of TFMD-derived carbenes.[20] Gel bands of the cross-
linked complexes were excised and the linker arm cleaved by
reduction of the disulfide (Figure 1 b) releasing MCL-1 bear-
ing the transferred thiol-containing tag at the interaction sites.
The free thiol in each tag was capped by alkylation with IAA
and the protein digested in-gel with trypsin (see Supporting
Information). Peptides modified with the transferred tag were
identified by LC-MS/MS. This allowed BID80–102 to be mapped
Figure 1. a) Structures of MTS-diazirine and MTS-TFMD. b) Crosslink-
ing workflow schematic: A Cys-containing bait protein is conjugated
with the reagent (here MTS-diazirine). After adding the target protein,
the sample is irradiated with 365 nm UV light, revealing a carbene that
reacts with the target. Reductant is added, leaving a sulfhydryl tag on
the target at the interaction site. c) Image of the UV LED lamp and
custom-built acrylic chip comprising a 33 mL sample well. See also
Figure S4a,b.
Figure 2. a) Densitometry quantification of the appearance of OmpA-
(W7C)[MTS-diazirine] crosslinked to Skp vs. irradiation time. Inset:
expanded time axis to show full time course using the Hg-Xe lamp.
Lines are exponential fits to the data. Relative intensity of crosslinked
product [%] was calculated as the intensity of the crosslinked product
band on an SDS-PAGE gel at time t divided by the intensity at tfinal,
assuming the maximal yield is achieved when the graph plateaus (see
example SDS-PAGE of the XL reaction (bottom) and Figure S4c).
b) Sample heating at irradiation times required to reach 15, 55 and
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into the MCL-1 binding groove unambiguously, in agreement
with the known “bind-and-fold” interaction[23] and NMR/X-
ray structures of the complex (Figure 3d, Tables S2 and S3,
Figures S6–S8).[15b,16] Both crosslinkers gave similar results
(Figure S6), demonstrating that the bulkier TFMD-diazirine
can be used even when sidechain interdigitation drives
association. Crosslinked positions on MCL-1 were quantified
by MS/MS from each Cys residue introduced into BID80–102
labelled with MTS-diazirine or MTS-TFMD. This revealed
that crosslinking yields were greater when the Ca–Ca
Euclidian distance of the residues in the complex was
< 10 c, but crosslinks could be detected for distances up to
15 c (Figures S9,S10).
We next tested the ability of our workflow and tag transfer
reagents to study a protein complex stabilised by transient
interactions. Chaperone-client binding often involves
a dynamic interaction of chaperones with an unfolded/
partially folded client protein to aid folding or prevent
aggregation.[24] These interfaces are challenging to map using
crosslinking since the interactions can be dynamic and diffuse.
Here, we used the interaction between the periplasmic
chaperone Skp from E. coli, and a b-barrel outer membrane
protein substrate, OmpA, as a model for this type of PPI.[25]
Skp, a homotrimer, has a jellyfish-like structure resulting in
a cage in which substrates are sequestered (Figure 4a).[25b,26]
Skp binds its OMP substrates with nm affinity,[17] similar to
that of the well-defined BID80-102/MCL-1 complex.
[15] How-
ever, Skp-bound OmpA is in a “fluid-globule” state that
forms many weak and transient interactions in the Skp
cage.[17, 18]
Two single Cys variants of
OmpA were generated, W7C and
T144C, located in the b-barrel and
a surface exposed loop in folded
OmpA, respectively.[18] MTS-diazir-
ine or MTS-TFMD conjugation of
both variants was efficient (Fig-
ure S11), and did not prevent fold-
ing (Figure S12). The Skp/OmpA
complex was assembled by dilution
of urea-denatured OmpA into
a Skp-containing solution, and PI-
XL was then performed. The cross-
linked Skp/OmpA complex was
detected by non-reducing SDS-
PAGE as a single band with an
apparent mass of approximately
70 kDa (Figure 4b). Four non-over-
lapping positions from OmpA-
(T144C) to residues within SkpQs
“cage” (Figure 4d (top); Fig-
ure S13) could be identified by in-
gel digestion of the crosslinked
proteins followed by LC-MS/MS
(Figure 5, Method 1). This result
was surprising since it is inconsis-
tent with previous studies which
have shown that OmpA tumbles
dynamically on a sub-ms timescale within Skp.[18] We rea-
soned that the lack of modified sites resulted from the
relatively low abundance of these peptides in the Skp-OmpA
complex, rather than reflecting a specific interaction surface
involving these four sites. Given that each Skp trimer binds
a single OmpA, and each OmpA contains only a single
crosslinker, then only one modified peptide would result from
each 70 kDa Skp/OmpA complex.
To test this conclusion we developed a protocol to enrich
chemically modified Skp, removing background peptides
arising from OmpA and unmodified Skp (Figure 5). We
used thiopropyl Sepharose 6B beads to purify Skp monomers
containing the thiol fragment obtained from the tag-transfer
reaction and the Cys-containing OmpA bait. The thiol-
containing proteins were then eluted from the resin, sepa-
rated by SDS-PAGE and trypsinised in-gel (Method 2).
Alternatively, trypsin digestion was performed on-bead[27] and
unbound peptides removed by washing the resin prior to
elution (Method 3). Using Method 2 the number of modified
peptides detected increased > 2-fold (from 6 to 14), whilst
Method 3 yielded a further 2.5-fold increase in the number of
modified peptides identified (from 14 to 35) (Figure 4d,
Figure S13), a ca. 6-fold increase in detection over Method 1.
No significant sidechain bias was observed for either cross-
linker (Figure S14), consistent with the reactivity of the
diazirine-derived carbenes.[9, 19b] Similar crosslinking sites
were observed for OmpA(W7C) and OmpA(T144C) using
both crosslinkers (Figures S13,S14). Using these enrichment
protocols modifications on Skp were identified all around the
internal cavity (Figure 4c), consistent with OmpA tumbling
randomly in Skp.[18] The ability to enrich crosslinked peptides
Figure 3. a) Sequence of WT BID80–102. Five Cys variants of BID80-102 were labelled with MTS-diazirine
or MTS-TFMD. Cys-substituted amino acids are shown as coloured spheres in the peptide structure
and in the same colour in the sequence above. b) Inhibitory potency (EC50) of BID80–102 labelled with
MTS-diazirine (left) or MTS-TFMD (right) to MCL-1 measured by fluorescence anisotropy (EC50
values are shown in Table S1). (c) SDS-PAGE of BID80–102 labelled with MTS-diazirine (top) or MTS-
TFMD (bottom) crosslinked to MCL-1. d) Residues of MCL-1 (magenta on a grey ribbon) that
crosslinked to at least one BID80–102 peptide labelled with MTS-diazirine (left) or MTS-TFMD (right).
BID80–102 is shown in cyan and residues substituted as Cys are coloured as in (a) (PDB ID: 2KBW
[16]).
See also Figures S6–S8, Tables S2, S3.
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using our tag-transfer protocol, combined with the promiscu-
ous reactivity of diazirines, exemplifies the power of the
technique to monitor even the most dynamic of protein
interfaces (Figure 4c & d).
In summary, we have demonstrated that Cys-containing
variants of a bait protein conjugated with MTS-diazirine or
MTS-TFMD-based tag-transfer crosslinkers can map PPIs in
both well-defined and dynamic interfaces. Since the location
of the crosslink in the bait protein is known and only the
transferred tag is considered in downstream analysis, the
background from bait peptides is removed and the search
space for crosslinked products is reduced. These features are
particularly important as target protein size increases. The
workflow described is simple to implement, only requiring the
appropriate crosslinking reagents, LC-MS/MS and proteo-
mics software for mapping PTMs. Enrichment and digestion
of modified peptides enables low protein concentrations to be
used, minimising the possibility of aggregation or other
aberrant interactions. Additionally, the custom UV LED
platform enables PI-XL on a 10 second timescale, not possible
with arc-based lamps, and only previously achieved using
pulsed lasers in solution or in the gas phase.[5,10a] The low cost
(& $300) and simplicity of our UV LED system makes these
timescales accessible to any researcher. Our workflow thus
opens the door to time-resolved XL on the second timescale
without the need for expensive lasers and enables the study of
conformational changes within dynamic protein complexes
versus time.
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